IE33929B1 - Adamantanyl alkylamine derivatives and their preparation - Google Patents
Adamantanyl alkylamine derivatives and their preparationInfo
- Publication number
- IE33929B1 IE33929B1 IE1170/69A IE117069A IE33929B1 IE 33929 B1 IE33929 B1 IE 33929B1 IE 1170/69 A IE1170/69 A IE 1170/69A IE 117069 A IE117069 A IE 117069A IE 33929 B1 IE33929 B1 IE 33929B1
- Authority
- IE
- Ireland
- Prior art keywords
- group
- atom
- hydrogen
- hydrogen atom
- alkyl group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
- C07C53/136—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems
- C07C53/138—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems containing an adamantane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/38—Acyl halides
- C07C53/44—Acyl halides containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/36—Acyl halides
- C07C55/38—Acyl halides containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pivots And Pivotal Connections (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Abstract
1,274,652. Antidepressant &c. compositions. LILLY INDUSTRIES Ltd. 28 Oct., 1969 [27 Aug., 1968], No. 40968/68. Heading A5B. [Also in Division C2] Pharmaceutical compositions having antidepressant, -Parkinsonism and -motion sickness and appetite suppressant activity comprise, as active ingredient, at least one 1-aminoalkyladamantane of the general formula wherein n is 1 or 2; R<SP>1</SP> is a hydrogen atom or a C 1-4 alkyl group or, when n is 1, R<SP>1</SP> and R<SP>4</SP> together form a methylene group; R<SP>2</SP> is a hydrogen atom or C 1-4 alkyl group or, when n is 1, a C 1-4 hydroxyalkyl or phenyl-C 1- 4 alkyl group, R<SP>3</SP> is a hydrogen atom or a C 1-4 alkyl group or, when R<SP>2</SP> is a hydrogen atom, R<SP>3</SP> is an amidino, pyrimidinyl or C 1-4 alkylpyrimidinyl group, or NR<SP>2</SP>R<SP>3</SP> is a pyrrolidino, piperidino, NC 1-4 alkylpiperazino or N-C 1-4 hydroxyalkylpiperazino group; R<SP>4</SP> is a hydrogen or chlorine atom or a phenyl group or, when n is 1, a bromine atom or cyclohexyl group; R<SP>5</SP> and R<SP>6</SP> are each a hydrogen atom or, when n is 1, a chlorine atom or phenyl group; provided that one of R<SP>4</SP>, R<SP>5</SP> and R<SP>6</SP> is not a chlorine atom and the others are hydrogen atoms or R<SP>4</SP> is not a bromine atom and R<SP>5</SP> and R<SP>6</SP> are hydrogen atoms, when R<SP>7</SP>, R<SP>8</SP> and R<SP>9</SP> are hydrogen atoms, R<SP>1</SP> is a hydrogen atom or a C 1-4 alkyl group, one of R<SP>2</SP> and R<SP>3</SP> is a hydrogen atom and the other is a C 1-4 alkyl group and n is 1; R<SP>7</SP> is a hydrogen or bromine atom or a hydroxyl or -(CH 2 ) n - -CHR a <SP>1</SP>-NR a <SP>2</SP>R a <SP>3</SP> group, wherein n is 1 or 2 and R a <SP>1</SP>, R a <SP>2</SP> and R a <SP>3</SP> are each a hydrogen atom or a C 1-4 alkyl group, or, when n is 1, R<SP>7</SP> is a methyl group; and R<SP>8</SP> and R<SP>9</SP> are each a hydrogen atom or, when n is 1, a methyl group; or pharmaceutically acceptable acid addition salt thereof, in association with a pharmaceutically acceptable carrier.
[GB1274652A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB40968/68A GB1274652A (en) | 1968-08-27 | 1968-08-27 | Adamantanyl-alkylamine derivatives and their preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE33929L IE33929L (en) | 1970-02-27 |
| IE33929B1 true IE33929B1 (en) | 1974-12-11 |
Family
ID=10417493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1170/69A IE33929B1 (en) | 1968-08-27 | 1969-08-27 | Adamantanyl alkylamine derivatives and their preparation |
Country Status (12)
| Country | Link |
|---|---|
| JP (3) | JPS4939257B1 (en) |
| AT (1) | AT307380B (en) |
| BE (1) | BE737975A (en) |
| CH (3) | CH538442A (en) |
| DE (1) | DE1943404A1 (en) |
| DK (1) | DK131721C (en) |
| FR (1) | FR2016468B1 (en) |
| GB (1) | GB1274652A (en) |
| IE (1) | IE33929B1 (en) |
| IL (1) | IL32892A (en) |
| NL (1) | NL6913046A (en) |
| SE (1) | SE364037B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS507356A (en) * | 1973-05-22 | 1975-01-25 | ||
| GB0013737D0 (en) | 2000-06-07 | 2000-07-26 | Astrazeneca Ab | Novel compounds |
| SE0103836D0 (en) * | 2001-11-16 | 2001-11-16 | Astrazeneca Ab | Novel compounds |
| SE0300480D0 (en) | 2003-02-21 | 2003-02-21 | Astrazeneca Ab | Novel compounds |
| GB0312609D0 (en) | 2003-06-02 | 2003-07-09 | Astrazeneca Ab | Novel compounds |
| ITTO20030668A1 (en) | 2003-09-02 | 2005-03-03 | Rotta Res Lab S P A O Ra Rottapharm | DERIVATIVES OF ADAMANTAN EQUIPPED WITH NEUROPROTECTIVE, ANTIDEPRESSIVE AND ANTI-ISCHEMIC ACTIVITY AND PROCEDURE FOR THEIR PREPARATION. |
| PE20091225A1 (en) | 2007-03-22 | 2009-09-16 | Astrazeneca Ab | QUINOLINE DERIVATIVES AS ANTAGONISTS OF THE P2X7 RECEPTOR |
| PE20091036A1 (en) | 2007-11-30 | 2009-08-15 | Astrazeneca Ab | QUINOLINE DERIVATIVE AS ANTAGONIST OF THE P2X7 RECEPTOR |
| CN109593042B (en) * | 2018-12-24 | 2021-12-07 | 陕西莱特迈思光电材料有限公司 | Organic electroluminescent material and organic electroluminescent device comprising same |
| CN114181091B (en) * | 2021-12-27 | 2024-06-14 | 维思普新材料（苏州）有限公司 | Synthesis process of adamantane triphenylamine |
-
1968
- 1968-08-27 GB GB40968/68A patent/GB1274652A/en not_active Expired
-
1969
- 1969-08-25 IL IL6932892A patent/IL32892A/en unknown
- 1969-08-26 CH CH1300669A patent/CH538442A/en not_active IP Right Cessation
- 1969-08-26 AT AT817269A patent/AT307380B/en active
- 1969-08-26 DK DK457869A patent/DK131721C/en active
- 1969-08-26 NL NL6913046A patent/NL6913046A/xx unknown
- 1969-08-26 CH CH143372A patent/CH553149A/en not_active IP Right Cessation
- 1969-08-26 DE DE19691943404 patent/DE1943404A1/en active Pending
- 1969-08-26 CH CH1435971A patent/CH551365A/en not_active IP Right Cessation
- 1969-08-26 SE SE11809/69A patent/SE364037B/xx unknown
- 1969-08-26 BE BE737975A patent/BE737975A/xx unknown
- 1969-08-27 FR FR696929356A patent/FR2016468B1/fr not_active Expired
- 1969-08-27 IE IE1170/69A patent/IE33929B1/en unknown
-
1972
- 1972-06-29 JP JP47064563A patent/JPS4939257B1/ja active Pending
- 1972-06-29 JP JP47064562A patent/JPS4939256B1/ja active Pending
- 1972-06-29 JP JP47064561A patent/JPS5010856B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE1943404A1 (en) | 1970-12-17 |
| JPS4939257B1 (en) | 1974-10-24 |
| SE364037B (en) | 1974-02-11 |
| IE33929L (en) | 1970-02-27 |
| GB1274652A (en) | 1972-05-17 |
| IL32892A0 (en) | 1969-11-12 |
| CH538442A (en) | 1973-06-30 |
| FR2016468A1 (en) | 1970-05-08 |
| CH551365A (en) | 1974-07-15 |
| DK131721B (en) | 1975-08-25 |
| NL6913046A (en) | 1970-03-03 |
| CH553149A (en) | 1974-08-30 |
| DK131721C (en) | 1976-01-26 |
| BE737975A (en) | 1970-02-26 |
| JPS5010856B1 (en) | 1975-04-24 |
| AT307380B (en) | 1973-05-25 |
| JPS4939256B1 (en) | 1974-10-24 |
| IL32892A (en) | 1975-04-25 |
| FR2016468B1 (en) | 1973-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE33929B1 (en) | Adamantanyl alkylamine derivatives and their preparation | |
| GB1260848A (en) | Propanolamine derivatives | |
| GB1180766A (en) | 2-Arylamine-1,3-Diazacycloalkenes-(2) and the Preparation Thereof | |
| GB1181673A (en) | Derivatives of Xanthen and Thiaxanthen and Preparation Thereof | |
| GB1185522A (en) | 00,5-(Iminomethano)-10,11-Dihydro-5H-Dibenzo [a,d]Cycloheptene and Derivatives | |
| GB1480836A (en) | Physiologically active xanthine derivatives and compositions containing them | |
| GB1352257A (en) | Pyridyltriazoles their preparation and compositions containing them | |
| GB1322451A (en) | 3-amino-5-benzyl-1,2,4-oxadiazoles | |
| GB1177145A (en) | Heterocyclic Allylic Amines | |
| GB1353486A (en) | Benzodiazepine derivatives | |
| GB1424432A (en) | Pharmaceutical compositions | |
| GB1352392A (en) | Phenylisopropylamine derivatives | |
| GB1314899A (en) | Thiosemicarbazones processes for their preparations and compositions incorporating them | |
| GB1193438A (en) | Barbituric Acid Derivatives, preparation thereof and Pharmaceutical Compositions containing them | |
| ES342394A1 (en) | Novel Benzylaminoimidazoline Derivatives, the preparation thereof and Compositions containing the same | |
| IE34313B1 (en) | 2-hydroxy-5-amino-benzamide derivatives | |
| GB1249512A (en) | 0,2,3,4-tetrahydro-7-halo-6-sulfamyl-4-quinazolinones, process for preparing the same and pharmaceutical compositions comprising the same | |
| GB1273399A (en) | Novel formamido-cycloalkane derivatives | |
| GB1188434A (en) | Guanidine Derivatives and their preparation | |
| GB1257264A (en) | ||
| SE329398B (en) | ||
| ES385521A1 (en) | Azamorphinan compounds | |
| IE33462B1 (en) | Benzodioxole compounds | |
| GB1457950A (en) | Antibacterial compositions | |
| GB1408408A (en) | Benzimidazole derivatives |